Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 13, 2018

SELL
$189.1 - $282.92 $404,863 - $605,731
-2,141 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$123.8 - $192.48 $265,055 - $412,099
2,141 New
2,141 $399,000
Q1 2018

May 15, 2018

SELL
$114.22 - $133.22 $249,570 - $291,085
-2,185 Closed
0 $0
Q4 2017

Feb 27, 2019

SELL
$93.4 - $128.74 $2,615 - $3,604
-28 Reduced 1.27%
2,185 $264,000
Q4 2017

Nov 21, 2018

BUY
$93.4 - $128.74 $2,615 - $3,604
28 Added 1.28%
2,213 $264,000
Q4 2017

Feb 14, 2018

BUY
$93.4 - $128.74 $204,079 - $281,296
2,185
2,185 $260,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $230M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Ibex Investors LLC Portfolio

Follow Ibex Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ibex Investors LLC with notifications on news.